Biography:
Pedro Plans-Rubió has been Responsible for Health Registries, Public Health Agency of Catalonia, Barcelona, Spain (1999-2025). MD from the School of Medicine, University of Barcelona; PhD from the School of Medicine, University of Barcelona; MSc in Health Economics from the School of Economics, University of Barcelona. Specialist in Preventive Medicine and Public Health. Member of the Group of Prioritization of Treatments (GIP), Heath Emergency Preparedness and Response (HERA), European Commission. Member of the Non-communicable diseases risk factor Collaboration (NCD-RisC) research group. Editor-in Chief of Section “Vaccine Advancement, Efficacy and Safety” of journal Vaccines. Member of the Editorial Board of journal Pharmacoeconomics Open, Elsevier.
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Title : COVID-19 vaccination strategies in the post-pandemic era
Title : Adapted mRNA COVID-19 vaccines have a limited ability to establish herd immunity in the population against Omicron BA.1 and BA4-5 variants of SARS-CoV-2
Title : Factors associated with non-adherence to tuberculosis (TB) preventive treatment among adult contacts of pulmonary TB cases with latent TB infection in Spain